Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Lyme disease is a tick-borne illness caused by the bacterium Borrelia burgdorferi , and approximately 10 to 20% of patients report persistent symptoms lasting months to years despite appropriate treatment with antibiotics. To gain insights into the molecular basis of acute Lyme disease and the ensuing development of post-treatment symptoms, we conducted a longitudinal transcriptome study of 29 Lyme disease patients (and 13 matched controls) enrolled at the time of diagnosis and followed for up to 6 months. The differential gene expression signature of Lyme disease following the acute phase of infection persisted for at least 3 weeks and had fewer than 44% differentially expressed genes (DEGs) in common with other infectious or noninfectious syndromes. Early Lyme disease prior to antibiotic therapy was characterized by marked upregulation of Toll-like receptor signaling but lack of activation of the inflammatory T-cell apoptotic and B-cell developmental pathways seen in other acute infectious syndromes. Six months after completion of therapy, Lyme disease patients were found to have 31 to 60% of their pathways in common with three different immune-mediated chronic diseases. No differential gene expression signature was observed between Lyme disease patients with resolved illness to those with persistent symptoms at 6 months post-treatment. The identification of a sustained differential gene expression signature in Lyme disease suggests that a panel of selected human host-based biomarkers may address the need for sensitive clinical diagnostics during the “window period” of infection prior to the appearance of a detectable antibody response and may also inform the development of new therapeutic targets. IMPORTANCE Lyme disease is the most common tick-borne infection in the United States, and some patients report lingering symptoms lasting months to years despite antibiotic treatment. To better understand the role of the human host response in acute Lyme disease and the development of post-treatment symptoms, we conducted the first longitudinal gene expression (transcriptome) study of patients enrolled at the time of diagnosis and followed up for up to 6 months after treatment. Importantly, we found that the gene expression signature of early Lyme disease is distinct from that of other acute infectious diseases and persists for at least 3 weeks following infection. This study also uncovered multiple previously undescribed pathways and genes that may be useful in the future as human host biomarkers for diagnosis and that constitute potential targets for the development of new therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, RNA-seq analyses of the human host can be used to identify novel or underappreciated host–microbial interactions directly from clinical samples, as previously shown for patients with Lyme disease68, dengue80 or malaria81.”
From Clinical metagenomics (2019) · cites this paper as [68]
In the citing paper
“Classification of genes by expression profiling using RNA-seq has been used to characterize several infections, including staphylococcal bacteraemia67, Lyme disease68, candidiasis69, tuberculosis (discriminating between latent and active disease risk)70–72 and influenza73–75.”
From Clinical metagenomics (2019) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155
Causal analysis approaches in Ingenuity Pathway Analysis
Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724 · cited 1×
“Avg age (yr) 52 (36–61) [20–71] 50 (42–61) [22–70] 0.”
Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508667 · Cited by 2,087
Stanek, G., Wormser, G. P., Gray, J., & Strle, F. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60103-7 · Cited by 1,237
Steere, A. C., Coburn, J., & Glickstein, L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421681 · Cited by 788
(1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530120023018 · Cited by 590
Gene expression patterns in blood leukocytes discriminate patients with acute infections
Ramilo, O., Allman, W., Chung, W., Mejias, A., Ardura, M., Glaser, C., Wittkowski, K. M., Piqueras, B., Banchereau, J., Palucka, A. K., et al. (2007) · Blood · doi:10.1182/blood-2006-02-002477 · Cited by 482
Lyme Disease Testing by Large Commercial Laboratories in the United States
Hinckley, A. F., Connally, N. P., Meek, J. I., Johnson, B. J., Kemperman, M. M., Feldman, K. A., White, J. L., & Mead, P. S. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu397 · Cited by 386
Calculating Sample Size Estimates for RNA Sequencing Data
Hart, S. N., Therneau, T. M., Zhang, Y., Poland, G. A., & Kocher, J.-P. (2013) · Journal of Computational Biology · doi:10.1089/cmb.2012.0283 · Cited by 341
Fold change and p-value cutoffs significantly alter microarray interpretations
Dalman, M. R., Deeter, A., Nimishakavi, G., & Duan, Z.-H. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-s2-s11 · Cited by 332
IgM in microbial infections: Taken for granted?
Racine, R., & Winslow, G. M. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.06.003 · Cited by 268
Therapy for Lyme arthritis: Strategies for the treatment of antibiotic‐refractory arthritis
Steere, A. C., & Angelis, S. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22131 · Cited by 244
Chronic Lyme Disease: A Review
Marques, A. (2008) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2007.12.011 · Cited by 227
Fontana, M. F., Banga, S., Barry, K. C., Shen, X., Tan, Y., Luo, Z.-Q., & Vance, R. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001289 · Cited by 226
Smeekens, S. P., Ng, A., Kumar, V., Johnson, M. D., Plantinga, T. S., van Diemen, C., Arts, P., Verwiel, E. T. P., Gresnigt, M. S., Fransen, K., et al. (2013) · Nature Communications · doi:10.1038/ncomms2343 · Cited by 213 · cited 1×
“Avg age (yr) 52 (36–61) [20–71] 50 (42–61) [22–70] 0.”
From expression to signaling: Roles of TREM-1 and TREM-2 in innate immunity and bacterial infection
Sharif, O., & Knapp, S. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.07.008 · Cited by 196
Large Scale Comparison of Gene Expression Levels by Microarrays and RNAseq Using TCGA Data
Guo, Y., Sheng, Q., Li, J., Ye, F., Samuels, D. C., & Shyr, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071462 · Cited by 191
Diagnostic challenges of early Lyme disease: Lessons from a community case series
Aucott, J. N., Morrison, C., Muñoz, B., Rowe, P. C., Schwarzwalder, A. W., & West, S. K. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-79 · Cited by 157
Self-citationLong-term follow-up of patients with culture-confirmed lyme disease
Nowakowski, J., Nadelman, R. B., Sell, R., McKenna, D. F., Cavaliere, L., Holmgren, D., Gaidici, A., & Wormser, G. P. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00308-5 · Cited by 151
Zhai, Y., Franco, L. M., Atmar, R. L., Quarles, J. M., Arden, N., Bucasas, K. L., Wells, J. M., Niño, D., Wang, X., Zapata, G. E., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004869 · Cited by 148
Borjesson, D. L., Kobayashi, S. D., Whitney, A. R., Voyich, J. M., Argue, C. M., & DeLeo, F. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6364 · Cited by 133
Development of a foundation for a case definition of post-treatment Lyme disease syndrome
Aucott, J. N., Crowder, L. A., & Kortte, K. B. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.01.008 · Cited by 124
Self-citationStrle, K., Stupica, D., Drouin, E. E., Steere, A. C., & Strle, F. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit735 · Cited by 123
Butchar, J. P., Cremer, T. J., Clay, C. D., Gavrilin, M. A., Wewers, M. D., Marsh, C. B., Schlesinger, L. S., & Tridandapani, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002924 · Cited by 119
Suppression of Long-Lived Humoral Immunity Following Borrelia burgdorferi Infection
Elsner, R. A., Hastey, C. J., Olsen, K. J., & Baumgarth, N. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004976 · Cited by 117
Schutzer, S. E., Angel, T. E., Liu, T., Schepmoes, A. A., Clauss, T. R., Adkins, J. N., Camp, D. G., Holland, B. K., Bergquist, J., Coyle, P. K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017287 · Cited by 117
TREM‐1 promotes survival during septic shock in mice
Gibot, S., Massin, F., Marcou, M., Taylor, V., Stidwill, R. P., Wilson, P., Singer, M., & Bellingan, G. J. (2007) · European Journal of Immunology · doi:10.1002/eji.200636387 · Cited by 108
TEIXEIRA, V. H., Olaso, R., Martin‐Magniette, M., Lasbleiz, S., Jacq, L., Oliveira, C. R., Hilliquin, P., Gut, I. G., Cornélis, F., & Petit, É. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006803 · Cited by 105
Three Sudden Cardiac Deaths Associated With Lyme Carditis—United States, November 2012 to July 2013
(2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000284 · Cited by 98
Development of a Metabolic Biosignature for Detection of Early Lyme Disease
Molins, C. R., Ashton, L. V., Wormser, G. P., Hess, A. M., Delorey, M. J., Mahapatra, S., Schriefer, M. E., & Belisle, J. T. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ185 · Cited by 94
Drouin, E. E., Seward, R., Strle, K., McHugh, G., Katchar, K., Londoño, D., Yao, C., Costello, C. E., & Steere, A. C. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37732 · Cited by 91
Survival strategies of Borrelia burgdorferi, the etiologic agent of Lyme disease
Embers, M. E., Ramamoorthy, R., & Philipp, M. T. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2003.11.014 · Cited by 85
Challenges in estimating percent inclusion of alternatively spliced junctions from RNA-seq data
Kakaradov, B., Xiong, H. Y., Lee, L. J., Jojic, N., & Frey, B. J. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-s6-s11 · Cited by 83
Serum Inflammatory Mediators as Markers of Human Lyme Disease Activity
Soloski, M. J., Crowder, L. A., Lahey, L. J., Wagner, C. A., Robinson, W. H., & Aucott, J. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093243 · Cited by 73
Self-citationThree sudden cardiac deaths associated with Lyme carditis - United States, November 2012-July 2013.
(2013) · PubMed Central · Cited by 70
A gene signature for post-infectious chronic fatigue syndrome
Gow, J. W., Hagan, S., Herzyk, P., Cannon, C., Behan, P. O., & Chaudhuri, A. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-38 · Cited by 69
Pianta, A., Drouin, E. E., Crowley, J. T., Arvikar, S. L., Strle, K., Costello, C. E., & Steere, A. C. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.07.005 · Cited by 59
Crowley, J. T., Drouin, E. E., Pianta, A., Strle, K., Wang, Q., Costello, C. E., & Steere, A. C. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv310 · Cited by 59
Sjöwall, J., Fryland, L., Nordberg, M., Sjögren, F., Garpmo, U., Jansson, C. C., Carlsson, S., Bergström, S., Ernerudh, J., Nyman, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018220 · Cited by 57
Grolleau‐Julius, A., Kaplan, M. J., Hanash, S., Beretta, L., & Richardson, B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9352 · Cited by 57
Microglia Are Mediators of Borrelia burgdorferi–Induced Apoptosis in SH-SY5Y Neuronal Cells
Myers, T. A., Kaushal, D., & Philipp, M. T. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000659 · Cited by 55
Innate immunity networks during infection withBorrelia burgdorferi
Oosting, M., Buffen, K., van der Meer, J. W. M., Netea, M. G., & Joosten, L. A. B. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.929563 · Cited by 46
Dame, T. M., Orenzoff, B. L., Palmer, L. E., & Furie, M. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.1172 · Cited by 37
TREM-1 modulation during early stages of dengue virus infection
Ruiz‐Pacheco, J. A., Vivanco-Cid, H., Izaguirre-Hernández, I. Y., Estrada‐García, I., Arriaga‐Pizano, L., Chacón‐Salinas, R., Fonseca-Coronado, S., Vaughan, G., Tovar, K., Rivera-Osorio, M. P., et al. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.01.003 · Cited by 34
Rheumatoid arthritis and systemic lupus erythematosus as immune complex diseases.
Weissmann, G. (2009) · PubMed · Cited by 30
Hou, J., van Oord, G. W., Groothuismink, Z. M. A., Claassen, M. A. A., Kreefft, K., Zaaraoui‐Boutahar, F., van IJcken, W. F. J., Osterhaus, A. D. M. E., Janssen, H. L. A., Andeweg, A. C., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00775-14 · Cited by 26
Moniuszko-Malinowska, A. M., Czupryna, P., Pancewicz, S. A., Rutkowski, K., Zajkowska, O., Świerzbińska, R., Grygorczuk, S., Kondrusik, M., Owłasiuk, P., & Zajkowska, J. M. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.11.002 · Cited by 23
Marques, A. R., Hornung, R. L., Dally, L., & Philipp, M. T. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.9.1036-1040.2005 · Cited by 22
Okazaki, T., Nishio, A., Takeo, M., Sakaguchi, Y., Fukui, T., Uchida, K., & Okazaki, K. (2014) · Digestion · doi:10.1159/000366414 · Cited by 20
Contribution of HLA alleles in the regulation of antibody production in lyme disease
Wang, P. (2001) · Frontiers in bioscience · doi:10.2741/wang · Cited by 17
Integrated stress response-altered pro-inflammatory signals in mucosal immune-related cells
Park, S., & Moon, Y. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.742535 · Cited by 15
Anti–Tumor Necrosis Factor–α Treatment for Lyme Borreliosis
McSweegan, E. (2007) · The Journal of Infectious Diseases · doi:10.1086/523828 · Cited by 4
Reply to Wormser et al. and to McSweegan
Yrjänäinen, H., Hytönen, J., Song, X.-Y., Oksi, J., Hartiala, K. T., & Viljanen, M. K. (2007) · The Journal of Infectious Diseases · doi:10.1086/523827 · Cited by 3
Cited by
Chiu, C. Y., & Miller, S. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0113-7 · Cited by 1,620
Self-citationAlevin efficiently estimates accurate gene abundances from dscRNA-seq data
Srivastava, A., Malik, L., Smith, T., Sudbery, I., & Patro, R. (2019) · Genome Biology · doi:10.1186/s13059-019-1670-y · Cited by 273
Radolf, J. D., Strle, K., Lemieux, J. E., & Strle, F. (2020) · Current Issues in Molecular Biology · doi:10.21775/cimb.042.333 · Cited by 220
Recent Progress in Lyme Disease and Remaining Challenges
Bobe, J. R., Jutras, B. L., Horn, E. J., Embers, M. E., Bailey, A., Moritz, R. L., Zhang, Y., Soloski, M. J., Ostfeld, R. S., Marconi, R. T., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.666554 · Cited by 199
Self-citationNetwork Medicine in the Age of Biomedical Big Data
Sonawane, A. R., Weiss, S. T., Glass, K., & Sharma, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00294 · Cited by 186
Metadata
- Authors
- Bouquet, J., Soloski, M. J., Swei, A., Cheadle, C., Federman, S., Billaud, J.-N., Rebman, A. W., Kabre, B., Halpert, R., Boorgula, M., Aucott, J. N., & Chiu, C. Y.
- Affiliations
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA
- Johns Hopkins University (US)
- San Francisco State University (US)
- University of California, San Francisco (US)
- Qiagen Bioinformatics, Redwood City, California, USA
- Qiagen (United States) (US)
- Corresponding author
- Aucott, John N.
- Chiu, Charles Y.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2016-03-02
- Volume
- 7
- Issue
- 1
- Pages
- e00100-16
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- PMC
- PMC4791844
- OpenAlex
- W2265193578
- Cited by
- 101
- References
- 56
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 9 · 2023: 7 · 2022: 13 · 2021: 14 · 2020: 12 · 2019: 12 · 2018: 7 · 2017: 6 · 2016: 7
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mBio (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Swartz Foundation
- Bay Area Lyme Foundation
- Stabler Foundation
- Lyme Research Alliance
- Lyme Disease Research Foundation, Inc.
- Office of Extramural Research, National Institutes of Health (HL105704, P30-AR05350)
- Abbott Laboratories
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
- Health Sciences › Medicine › Infectious Diseases › Brucella: diagnosis, epidemiology, treatment
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- Lyme disease, Borrelia burgdorferi, post-treatment Lyme disease syndrome, differential gene expression, host immune response, Toll-like receptor signaling, persistent symptoms, host biomarkers, T cell apoptosis, B cell development, tick-borne diseases
- MeSH terms
- Adult, Animals, Female, Humans, Lyme Disease, Male, Middle Aged, United States, Biomarkers, Gene Expression Profiling, Borrelia burgdorferi, Metabolic Networks and Pathways, High-Throughput Nucleotide Sequencing, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.